Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.28155
Abstract: Neoadjuvant immunotherapy (NIT) with checkpoint blockade has been increasingly studied for soft tissue sarcomas, however, survival outcomes data are limited, and dedifferentiated liposarcoma (DDLPS) histology remains underrepresented in recent trial cohorts. We assessed the impact… read more here.
Keywords: immunotherapy resectable; neoadjuvant immunotherapy; liposarcoma national; resectable dedifferentiated ... See more keywords